Creative Planning’s Genocea Biosciences, Inc. GNCA Stock Holding History

Creative Planning’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,138	Closed	-$15K	–	2173
2019 Q1	$15K	Hold	3,138	–	–	﹤0.01%	1860
2018 Q4	$7K	Buy	+3,138	New	+$15.6K	﹤0.01%	1855
2017 Q1	–	Sell	-250	Closed	-$8K	–	5042
2016 Q4	$8K	Buy	+250	New	+$8.23K	﹤0.01%	3722

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Creative Planning's GNCA Position: Q2 2019 in Review

Creative Planning sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2019, closing a stake of 3,138 shares — an estimated $15K sold.

Creative Planning first reported a position in GNCA in Q4 2016 and held it in 3 quarters. The position peaked at $15K in Q1 2019. 45 funds tracked by Wall St. Rank hold GNCA as of Q2 2019.

Creative Planning reported no remaining Genocea Biosciences, Inc. position as of Q2 2019 after selling out during the quarter.
Creative Planning sold 3,138 Genocea Biosciences, Inc. shares in Q2 2019, an estimated $15K.
Creative Planning first reported a position in Genocea Biosciences, Inc. in Q4 2016 and held it in 3 quarters.
Creative Planning's Genocea Biosciences, Inc. position peaked at $15K in Q1 2019.
45 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2019.

Based on Creative Planning's 13F filing for Q2 2019, filed 26 Jul 2019.